Stock detail

Meiragtx (MGTX) stock price, chart, and key data

View Meiragtx stock price, chart movement, and headline metrics on Woodstock's stock detail page.

MGTX

Stock detail

Meiragtx

MGTX · XNAS

-$0.07 (-0.58%) past day

$12.10

XNAS24/5 tradingLast updated: Jul 25, 01:01 PM

Key metrics

Financials

Quarterly revenue, profitability, and balance-sheet snapshot

0.19-0.01-0.21-0.42-0.62
FY2025 Q2Reported Revenue: $4MExpected Revenue: $6MNet income: -$39M
FY2025 Q3Reported Revenue: $410,000Expected Revenue: $7MNet income: -$51MExpected EPS: -0.62
FY2025 Q4Reported Revenue: $75MExpected Revenue: $4MNet income: $15MReported EPS: 0.19Expected EPS: 0.19
FY2026 Q1Reported Revenue: $293,000Expected Revenue: $17MNet income: -$46MExpected EPS: -0.57
FY2026 Q2Expected Revenue: $21M
FY2026 Q3Expected Revenue: $6M
75.4M50.2M25M-162.2K-25.3M-50.5M
FY25 Q2Q3Q4FY26 Q1Q2Q3

Operating income & Operating cash flow

Quarterly revenue, profitability, and balance-sheet snapshot

46.6M28.1M9.6M-9M-27.5M-46.1M
FY2024 Q4Operating income: -$31MOperating cash flow: -$23M
FY2025 Q1Operating income: -$42MOperating cash flow: -$37M
FY2025 Q2Operating income: -$45MOperating cash flow: -$44M
FY2025 Q3Operating income: -$46MOperating cash flow: -$12M
FY2025 Q4Operating income: $26MOperating cash flow: $47M
FY2026 Q1Operating income: -$41MOperating cash flow: $18M
FY24 Q4FY25 Q1Q2Q3Q4FY26 Q1

Total assets & Total liabilities

Quarterly revenue, profitability, and balance-sheet snapshot

302.8M242.2M181.7M121.1M60.6M0
FY2024 Q4Total assets: $270MTotal liabilities: $202M
FY2025 Q1Total assets: $224MTotal liabilities: $191M
FY2025 Q2Total assets: $199MTotal liabilities: $196M
FY2025 Q3Total assets: $189MTotal liabilities: $230M
FY2025 Q4Total assets: $244MTotal liabilities: $250M
FY2026 Q1Total assets: $245MTotal liabilities: $303M
FY24 Q4FY25 Q1Q2Q3Q4FY26 Q1

Total equity & Shares outstanding

Quarterly revenue, profitability, and balance-sheet snapshot

92.6M62.5M32.3M2.2M-28M-58.1M
FY2024 Q4Total equity: $68MShares outstanding: 78.9M
FY2025 Q1Total equity: $33MShares outstanding: 80.4M
FY2025 Q2Total equity: $3MShares outstanding: 80.4M
FY2025 Q3Total equity: -$41MShares outstanding: 80.5M
FY2025 Q4Total equity: -$6MShares outstanding: 81.4M
FY2026 Q1Total equity: -$58MShares outstanding: 92.6M
FY24 Q4FY25 Q1Q2Q3Q4FY26 Q1

Day range

$11.71 - $12.36

Close price

$12.10

Market cap

$1.1B

P/E ratio

-21.22

Financials

FY2026 Q1

Operating income

-$41M

Operating cash flow

$18M

EPS

Shares outstanding

92.6M

Total assets

$245M

Total equity

-$58M

Total liabilities

$303M

About the company

MEIRAGTX HLD

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Analyst rating summary

A current read on analyst sentiment from the insight feed.

Mean target

$25.00

Current price $11.77
Low$19.00High$35.00

7

Buy

/ 7

Recent calls

07/09/2026

Cantor Fitzgerald

Joshua Schimmer

Buy · Price target $20.00

07/08/2026

RBC Capital

Luca Issi

Buy · Price target $26.00

07/08/2026

Piper Sandler

Allison Bratzel

Buy · Price target $30.00

Ticker holders

Review politician disclosures and insider transactions in tabs.

No holder data is available for this category yet.

Market action

A concise summary of the latest filing, transaction, or market-moving item.

Latest EDGAR 4 filed on 2026-07-07, report date 2026-07-07: Naylor Stuart / MeiraGTx Holdings plc reports ownership changes; on 07/07/2026; in Ordinary Shares; including 2,547 shares at 13.86 per share; 665,958 shares at 14.9 per share; 25,112 shares at 14.9 per share; 1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2025. 2. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $13.36 to $14.31, inclusive. 3. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. 4. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $14.47 to $15.33, inclusive. /s/ Richard Giroux, Attorney-in-fact for Stuart Naylor ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

24/5 Trading

Act on the stock when the timing works for you.

With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.

*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.

Download the app
24/5 trading chart preview

Sign Up

Scan the QR code to get started

Contact via LINE

Scan the QR code to get started

LINE QR Code